Marta Szajnik
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
External cephalic version in nonvertex second twin-Success rate, mode of delivery, and safety: A systematic review.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: July 31, 2024
Culture Shock: An Investigation into the Tolerance of Pathogenic Biofilms to Antiseptics in Environments Resembling the Chronic Wound Milieu.
Journal: International journal of molecular sciences
Published: November 16, 2023
The Role of Soy Isoflavones in the Prevention of Bone Loss in Postmenopausal Women: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.
Journal: Journal of clinical medicine
Published: June 29, 2022
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma.
Journal: Nature communications
Published: October 21, 2018
Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.
Journal: Expert review of molecular diagnostics
Published: June 09, 2016
Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.
Journal: Gynecology & obstetrics (Sunnyvale, Calif.)
Published: January 28, 2014
Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.
Journal: Cell reports
Published: October 29, 2012
17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
Journal: Gynecologic oncology
Published: May 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026